FARALLON CAPITAL MANAGEMENT, L.L.C.
Institutional investor · Portfolio as of Q4 2024
Top Holdings151 positions
STATE STR SPDR S&P 500 ETF T | 4.2M | $2.4B | 10.7% | — | — | — | Decreased — |
HESS CORP | 6.4M | $857.2M | 3.8% | — | — | 5 qtrssince 2023-Q4 | Unchanged 0 |
EXELIXIS INC | 23.4M | $780.5M | 3.4% | $19.40 | +71.61% | 25 qtrssince 2018-Q4 | Decreased 0 |
INVESCO EXCHANGE TRADED FD T | 4.4M | $771M | 3.4% | — | — | — | Unchanged — |
UNITEDHEALTH GROUP INC | 1.5M | $739.8M | 3.2% | $459.90 | +5.27% | 8 qtrssince 2023-Q1 | Increased 75 |
DISCOVER FINL SVCS | 4.3M | $738M | 3.2% | — | — | 4 qtrssince 2024-Q1 | Increased 94 |
NATERA INC | 4.4M | $701.5M | 3.1% | $67.01 | +136.25% | 15 qtrssince 2021-Q2 | Decreased 0 |
MICROSOFT CORP | 1.6M | $688.4M | 3.0% | $268.03 | +55.12% | 25 qtrssince 2018-Q4 | Increased 65 |
AON PLC | 1.8M | $658.2M | 2.9% | $306.68 | +16.10% | 4 qtrssince 2024-Q1 | Increased 58 |
THERMO FISHER SCIENTIFIC INC | 1.2M | $641.6M | 2.8% | $467.67 | +10.54% | 21 qtrssince 2019-Q4 | Increased 81 |
IQVIA HLDGS INC | 3.1M | $613.7M | 2.7% | $170.94 | +15.51% | 25 qtrssince 2018-Q4 | Decreased 0 |
REVOLUTION MEDICINES INC | 13.2M | $579.5M | 2.5% | $34.63 | +24.67% | 16 qtrssince 2021-Q1 | Increased 63 |
AUTODESK INC | 1.8M | $544.4M | 2.4% | $297.53 | 0.00% | 1 qtr | New 81 |
TRANSUNION | 5.3M | $493.8M | 2.2% | $86.03 | +7.24% | 25 qtrssince 2018-Q4 | Decreased 0 |
DISNEY WALT CO | 4.4M | $493.1M | 2.2% | $95.59 | +14.34% | 3 qtrssince 2024-Q2 | Decreased 0 |
ISHARES TR | 3.6M | $476M | 2.1% | — | — | — | Increased — |
LANTHEUS HLDGS INC | 5.3M | $475.6M | 2.1% | $83.36 | +6.92% | 8 qtrssince 2023-Q1 | Increased 82 |
INTUIT | 753,758 | $473.7M | 2.1% | $455.81 | +37.12% | 9 qtrssince 2022-Q4 | Increased 64 |
BOSTON SCIENTIFIC CORP | 5M | $448.7M | 2.0% | $51.57 | +73.20% | 18 qtrssince 2020-Q3 | Decreased 0 |
ARAMARK | 11.4M | $425.7M | 1.9% | $25.80 | +42.22% | 17 qtrssince 2020-Q4 | Decreased 0 |
FARALLON CAPITAL MANAGEMENT, L.L.C. manages $22.8B across 151 positions as of Q4 2024. Top holdings: SPY puts (10.7%), HES (3.8%), EXEL (3.4%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 1/5.0.
Active quarter - 24 new positions, 38 exits, 36 increased. Top move: DFS (INCREASED, conviction 94). Portfolio: $22.8B across 151 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR